Pharmacology Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacology, including details on pharmacogenomics, drug development, new medications.

Volume 2 (2006), Issue 3 (March)

1. Use of a chemical probe to increase safety for human volunteers in toxicokinetic studies.
   Risk Anal, 25(6): 1559-71. [Abstract] [Full-text]
2. Integration of genomic data for pharmacology and toxicology using Internet resources.
   SAR QSAR Environ Res, 17(1): 25-36. [Abstract] [Full-text]
3. Pharmacogenetics in clinical practice: considerations for testing.
   Expert Rev Mol Diagn, 6(2): 193-205. [Abstract] [Full-text]
4. Clinical genomics data standards for pharmacogenetics and pharmacogenomics.
   Pharmacogenomics, 7(2): 247-53. [Abstract] [Full-text]
5. Teaching and practicing pharmacogenomics: a complex matter.
   Pharmacogenomics, 7(2): 243-6. [Abstract] [Full-text]
6. Pharmacogenomic data sample collection and storage: ethical issues and policy approaches.
   Pharmacogenomics, 7(2): 219-26. [Abstract] [Full-text]
7. Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies.
   Pharmacogenomics, 7(2): 187-202. [Abstract] [Full-text]
8. Development of a toxicogenomics in vitro assay for the efficient characterization of compounds.
   Pharmacogenomics, 7(2): 177-86. [Abstract] [Full-text]
9. Comparison of the TaqMan and LightCycler systems in pharmacogenetic testing: evaluation of CYP2C9*2/*3 polymorphisms.
   Clin Chem Lab Med, 44(3): 285-7. [Abstract] [Full-text]
10. Drugs and double binds: racial identification and pharmacogenomics in a system of binary race logic.
    Health Commun, 19(1): 61-73. [Abstract] [Full-text]
11. The promise of personalized medicine: a conversation with Michael Svinte. Interview by Michael Millenson.
    Health Aff (Millwood), 25(2): w54-60. [Abstract] [Full-text]
12. Psychopharmacologic treatment in juvenile offenders.
    Child Adolesc Psychiatr Clin N Am, 15(2): 477-99, x. [Abstract] [Full-text]
13. dbZach: A MIAME-compliant toxicogenomic supportive relational database.
    Toxicol Sci, 90(2): 558-68. [Abstract] [Full-text]
14. Role of pharmacogenetics in irinotecan therapy.
    Cancer Lett, 234(1): 90-106. [Abstract] [Full-text]
15. Priority setting in the REACH system.
    Toxicol Sci, 90(2): 304-8. [Abstract] [Full-text]
16. A role for physicians in ethnopharmacology and drug discovery.
    J Ethnopharmacol, 104(3): 297-301. [Abstract] [Full-text]
17. Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster.
    Pharmacogenet Genomics, 16(4): 287-96. [Abstract] [Full-text]
18. Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomics.
    Pharmacogenet Genomics, 16(4): 265-77. [Abstract] [Full-text]
19. Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government.
    J Am Acad Child Adolesc Psychiatry, 45(3): 261-70. [Abstract] [Full-text]
20. Dictyostelium discoideum to human cells: pharmacogenetic studies demonstrate a role for sphingolipids in chemoresistance.
    Biochim Biophys Acta, 1760(3): 301-9. [Abstract] [Full-text]
21. Chemical effects in biological systems (CEBS) object model for toxicology data, SysTox-OM: design and application.
    Bioinformatics, 22(7): 874-82. [Abstract] [Full-text]
22. Cytochrome P450 pharmacogenetics and cancer.
    Oncogene, 25(11): 1679-91. [Abstract] [Full-text]
23. Pharmacogenetics of human cytosolic sulfotransferases.
    Oncogene, 25(11): 1673-8. [Abstract] [Full-text]
24. Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer.
    Oncogene, 25(11): 1659-72. [Abstract] [Full-text]
25. Herbal products and their association with substance use in adolescents.
    J Adolesc Health, 38(4): 395-400. [Abstract] [Full-text]
26. Psychodynamic Trojan horses: using psychopharmacology to teach psychodynamics.
    J Am Acad Psychoanal Dyn Psychiatry, 34(1): 151-61. [Abstract] [Full-text]
27. Utilization of a toxicogenomic biomarker for evaluation of chemical-induced glutathione deficiency in rat livers across the GeneChip data of different generations.
    Toxicol Lett, 163(2): 161-9. [Abstract] [Full-text]
28. Race and ethnicity in the era of emerging pharmacogenomics.
    J Clin Pharmacol, 46(4): 405-7. [Abstract] [Full-text]
29. What race and ethnicity measure in pharmacologic research.
    J Clin Pharmacol, 46(4): 401-4. [Abstract] [Full-text]
30. Intervention for autistic spectrum disorders.
    NeuroRx, 3(2): 207-16. [Abstract] [Full-text]
31. Tackling the need to teach integrative pharmacology and physiology: problems and ways forward.
    Trends Pharmacol Sci, 27(3): 130-3. [Abstract] [Full-text]
32. Behavioural pharmacology: 40+ years of progress, with a focus on glutamate receptors and cognition.
    Trends Pharmacol Sci, 27(3): 141-8. [Abstract] [Full-text]
33. The quantitative analysis of drug-receptor interactions: a short history.
    Trends Pharmacol Sci, 27(3): 149-57. [Abstract] [Full-text]
34. A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists.
    Trends Pharmacol Sci, 27(3): 134-40. [Abstract] [Full-text]
35. A brief history of British Pharmacological Society meetings.
    Trends Pharmacol Sci, 27(3): 177-81. [Abstract] [Full-text]
36. Utilizing the laboratory in the poisoned patient.
    Clin Lab Med, 26(1): 13-30, vii. [Abstract] [Full-text]
37. Study design and rationale of a mock phase I trial as an educational tool for clinical pharmacology residents.
    Contemp Clin Trials, 27(2): 183-7. [Abstract] [Full-text]
38. Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models.
    Toxicology, 221(2): 241-8. [Abstract] [Full-text]

© 2005-2008 Pharmacology Research Today. All Rights Reserved.